MENU
+Compare
ETON
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$16.90
Change
-$0.56 (-3.21%)
Capitalization
468.22M

ETON Eton Pharmaceuticals Forecast, Technical & Fundamental Analysis

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company... Show more

ETON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ETON with price predictions
Nov 12, 2025

ETON in downward trend: price dove below 50-day moving average on November 07, 2025

ETON moved below its 50-day moving average on November 07, 2025 date and that indicates a change from an upward trend to a downward trend. In of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ETON as a result. In of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ETON turned negative on November 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for ETON crossed bearishly below the 50-day moving average on October 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ETON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ETON entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ETON advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

ETON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ETON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.243) is normal, around the industry mean (18.827). P/E Ratio (124.000) is within average values for comparable stocks, (71.764). ETON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). ETON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (6.631) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ETON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ETON is expected to report earnings to rise 475.00% to 23 cents per share on March 12

Eton Pharmaceuticals ETON Stock Earnings Reports
Q4'25
Est.
$0.23
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.04
Q3'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of 3 cents, missing the estimate of 10 cents. With 119.54K shares outstanding, the current market capitalization sits at 468.22M.
A.I. Advisor
published General Information

General Information

a developer of sterile injectable products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
21925 West Field Parkway
Phone
+1 847 787-7361
Employees
30
Web
https://www.etonpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIICX18.80N/A
N/A
Fidelity Advisor Mid Cap II C
FIKVX14.41N/A
N/A
Fidelity Advisor Asset Manager 20% Z
MGKQX14.97N/A
N/A
Morgan Stanley Global Permanence R6
VYSGX15.70-0.01
-0.06%
Voya MI Dynamic Small Cap W
NSNCX53.26-0.32
-0.60%
Neuberger Berman Small Cap Growth C

ETON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-1.13%
MDGL - ETON
34%
Loosely correlated
-2.32%
VKTX - ETON
31%
Poorly correlated
+0.44%
LBTSF - ETON
30%
Poorly correlated
N/A
ARRY - ETON
30%
Poorly correlated
-8.69%
FDMT - ETON
29%
Poorly correlated
+1.57%
More

Groups containing ETON

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-1.13%
Pharmaceuticals: Generic
industry (214 stocks)
28%
Poorly correlated
-1.00%